NRD
TXG icon

Nebula Research & Development’s 10x Genomics TXG Stock Holding History

Nebula Research & Development’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22,782
Closed -$327K – 1148
2024
Q4 		$327K Buy
22,782
+9,724
+74% +$153K 0.04% 690
2024
Q3 		$295K Buy
+13,058
New +$270K 0.04% 720
2024
Q2 		– Sell
-40,937
Closed -$1.54M – 1054
2024
Q1 		$1.54M Buy
+40,937
New +$1.8M 0.33% 47

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nebula Research & Development's TXG Position: Q1 2025 in Review

Nebula Research & Development sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 22,782 shares — an estimated $327K sold.

Nebula Research & Development first reported a position in TXG in Q1 2024 and held it in 3 quarters. The position peaked at $1.54M in Q1 2024. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • Nebula Research & Development reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
  • Nebula Research & Development sold 22,782 10x Genomics shares in Q1 2025, an estimated $327K.
  • Nebula Research & Development first reported a position in 10x Genomics in Q1 2024 and held it in 3 quarters.
  • Nebula Research & Development's 10x Genomics position peaked at $1.54M in Q1 2024.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on Nebula Research & Development's 13F filing for Q1 2025, filed 15 May 2025.